Offering a blood test as a secondary option boosts CRC screening by nearly twofold (Healio)

Key takeaways:

• Offering a blood test as a secondary option in individuals who previously declined colonoscopy or FIT increased CRC screening by 7.5%.
• There was no decrease in uptake of first-line screening options.

Compared with reoffering colonoscopy and fecal immunochemical test alone, offering a blood test as a secondary option resulted in a nearly twofold increase in colorectal cancer screening in veterans who had declined first-line screening.